LIN.US

479.76

+0.38%↑

BHP.UK

2,572

+1.74%↑

BHP.US

68.82

+0.89%↑

RIO.US

86.59

+0.99%↑

SCCO

159.24

-0.16%↓

LIN.US

479.76

+0.38%↑

BHP.UK

2,572

+1.74%↑

BHP.US

68.82

+0.89%↑

RIO.US

86.59

+0.99%↑

SCCO

159.24

-0.16%↓

LIN.US

479.76

+0.38%↑

BHP.UK

2,572

+1.74%↑

BHP.US

68.82

+0.89%↑

RIO.US

86.59

+0.99%↑

SCCO

159.24

-0.16%↓

LIN.US

479.76

+0.38%↑

BHP.UK

2,572

+1.74%↑

BHP.US

68.82

+0.89%↑

RIO.US

86.59

+0.99%↑

SCCO

159.24

-0.16%↓

LIN.US

479.76

+0.38%↑

BHP.UK

2,572

+1.74%↑

BHP.US

68.82

+0.89%↑

RIO.US

86.59

+0.99%↑

SCCO

159.24

-0.16%↓

Search

Martin Marietta Materials Inc

Suletud

SektorToorained

576.42 -0.38

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

565.94

Max

586.98

Põhinäitajad

By Trading Economics

Sissetulek

-135M

279M

Müük

-312M

1.5B

P/E

Sektori keskmine

35.843

34.302

Aktsiakasum

4.62

Dividenditootlus

0.56

Kasumimarginaal

18.188

Töötajad

9,600

EBITDA

-29M

493M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+22.44% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

0.56%

2.86%

Järgmine tulemuste avaldamine

29. apr 2026

Järgmine dividendimakse kuupäev

31. märts 2026

Järgmine aktsia dividendi kuupäev (ex-date)

1. juuni 2026

Turustatistika

By TradingEconomics

Turukapital

-6.7B

35B

Eelmine avamishind

576.8

Eelmine sulgemishind

576.42

Uudiste sentiment

By Acuity

73%

27%

145 / 151 Pingereas Basic materials

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

Martin Marietta Materials Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

23. märts 2026, 23:47 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23. märts 2026, 22:55 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23. märts 2026, 21:51 UTC

Omandamised, ülevõtmised, äriostud

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23. märts 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23. märts 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23. märts 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23. märts 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23. märts 2026, 22:42 UTC

Market Talk
Uudisväärsed sündmused

Global Equities Roundup: Market Talk

23. märts 2026, 22:42 UTC

Market Talk
Uudisväärsed sündmused

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23. märts 2026, 22:40 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23. märts 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23. märts 2026, 22:22 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23. märts 2026, 22:21 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23. märts 2026, 22:21 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23. märts 2026, 22:20 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23. märts 2026, 22:20 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23. märts 2026, 22:19 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23. märts 2026, 22:19 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23. märts 2026, 22:18 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23. märts 2026, 22:15 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23. märts 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23. märts 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23. märts 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23. märts 2026, 21:32 UTC

Tulu

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23. märts 2026, 21:32 UTC

Tulu

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23. märts 2026, 21:32 UTC

Tulu

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23. märts 2026, 21:10 UTC

Uudisväärsed sündmused

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23. märts 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23. märts 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23. märts 2026, 20:50 UTC

Market Talk
Tulu
Uudisväärsed sündmused

Basic Materials Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

Martin Marietta Materials Inc Prognoos

Hinnasiht

By TipRanks

22.44% tõus

12 kuu keskmine prognoos

Keskmine 707.23 USD  22.44%

Kõrge 804 USD

Madal 612 USD

Põhineb 15 Wall Streeti analüütiku instrumendi Martin Marietta Materials Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

15 ratings

8

Osta

7

Hoia

0

Müü

Tehniline skoor

By Trading Central

533.69 / 542.19Toetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Strong Bullish Evidence

Pikk perspektiiv

Weak Bullish Evidence

Sentiment

By Acuity

145 / 151 Pingereas Toorained

Uudiste sentiment

Tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Martin Marietta Materials Inc

Martin Marietta Materials, Inc., a natural resource-based building materials company, supplies aggregates and heavy-side building materials to the construction industry in the United States and internationally. It offers crushed stone, sand, and gravel products; ready mixed concrete and asphalt; paving products and services; and Portland and specialty cement for use in the infrastructure projects, and nonresidential and residential construction markets, as well as in the railroad, agricultural, utility, and environmental industries. The company also produces magnesia-based chemicals products; dolomitic lime primarily to customers for steel production and soil stabilization; and cement treated materials. Its chemical products are used in flame retardants, wastewater treatment, pulp and paper production, and other environmental applications. The company was founded in 1939 and is headquartered in Raleigh, North Carolina.
help-icon Live chat